| 产品名称: | Saccharopolyspora erythraea (Waksman) Labeda |
|---|---|
| 商品货号: | TS196148 |
| Deposited As: | Streptomyces erythraeus (Waksman) Waksman and Henrici |
| Strain Designations: | LMC 1648 |
| Application: | Produces erythronolide complex |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®: | no |
| Type Strain: | no |
| Medium: | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions: | Temperature: 26.0°C |
| Name of Depositor: | R Spagnoli |
| U.S. Patent Number: | |
| References: | Toscano L, Cappelletti LM. Semisynthetic macrolide antibiotics, intermediate compounds for their preparation and related pharmaceutical compositions containing them. US Patent 4,439,426 dated Mar 27 1984 |